We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Gene Variants Indicate Increased Susceptibility to Colon Cancer

By LabMedica International staff writers
Posted on 08 Mar 2012
Print article
The imbalance observed in the human tumor tissues appears to be the result of a complex, multistep process by the enzyme sarcoma tyrosine kinase (SRC).

Some tissues, like liver, have just one type of variant of the nuclear receptor hepatocyte nuclear factor 4α (HNF4α), but the colon has both P1 and P2 variants. The P1 variant is found in the nuclei of cells in the normal colon, but in the human colon cancer samples this variant is frequently either absent or located outside of the nucleus and, presumably, no longer functional.

An international team led by cell biologists at the University of California, (Riverside, CA, USA) has uncovered a new insight into colon cancer. The team analyzed about 450 human colon cancer specimens and found that in nearly 80% of them, the variants of the HNF4A gene are out of balance. The team used both SRC kinase assays and human colonic adenocarcinoma tissue staining. Tissue microarrays (TMAs) were constructed with 1.0 mm cores from morphologically representative areas of the original archived paraffin blocks, the central region of the tumor, deep advancing tumor front, and adjacent non-neoplastic mucosa using an Advanced Tissue Arrayer, ATA-100.

SRC kinase has been known to be activated in colon cancer but, until now, it was not known to act on the HNF4α protein. The cell biologists found that activated SRC modifies the P1 but not the P2 variant. The net result is loss of the P1 variant in the nuclei of cells in the colon. Another factor that increased a person's susceptibility to the disease was specific single nucleotide polymorphisms or SNPs located in the HNF4A gene. An SNP is a DNA sequence variation, a minor change in the genomic sequence that accounts for the variations seen between individuals. SNPs are the most common type of genetic variation among people. The SRC kinase assays and the ATA-100 used are manufactured by Millipore (Billerica, MA, USA).

The authors concluded that that increased staining for active SRC is associated with a loss of nuclear P1-HNF4α in a sizeable cohort of human colorectal tumors. Their findings suggest a unique link between an oncogenic kinase, a potent differentiation factor, and human colon cancer. Frances M. Sladek, PhD, a professor of cell biology and toxicologist, who was the lead author of the study said, "Loss of nuclear P1 HNF4α protein in the colon may be an early sign of colon cancer. A healthy colon has a good but delicate balance of the two HNF4A variants. If you could prevent the loss of the P1 variant via drugs, you might be able to maintain a normal colon and prevent colon cancer." The study was published on Febraury 14, 2012, in the Proceedings of the National Academy of Science of the United States (PNAS).

Related Links:
University of California, Riverside
Millipore

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.